Why Psyche

About Psychē Systems

For more than four decades, Psychē Systems has been about continuously innovating and delivering a robust portfolio consisting of specialty laboratory information systems (LIS). We help medical laboratories of every type and size successfully optimize both efficiency and cost-effectiveness.
Our diverse offerings provide seamlessly integrated systems to hospital, commercial, and clinical labs, along with extensive interfacing capabilities that support automation with diagnostic instruments, practice management systems (PMS), HIS and LIS software, reference laboratories, and billing networks.

Medical Laboratory Information Software Since 1976

Psychē Systems’ advanced solutions include our best-of-breed LIS applications including NucleoLIS® and WindoPath®. NucleoLIS supports molecular, cytogenetic, toxicology, and clinical lab testing. WindoPath is a fully CAP- and CLIA-compliant application that supports anatomic pathology and niche areas such as dermatopathology, gastroenterology, and urology.

In addition, we offer a full suite of robust connectivity solutions, including automatic ordering with ē.Outreach, comprehensive electronic medical record (EMR) integration, and interfacing to laboratory instruments and other third-party systems. All our solutions can be securely hosted on-premise or within our hosted services environment.

Our Products

Enterprise Level products

WindoPath® Ē.ssential

nucleoLIS is tailored to the unique workflows of PCR, immunology and FISH. It is also used for karyotyping, DNA sequencing, next gen sequencing, pharmacogenomics, toxicology, and other laboratory-defined tests.

nucleoLIS® Ē.finity

nucleoLIS is tailored to the unique workflows of PCR, immunology and FISH. It is also used for karyotyping, DNA sequencing, next gen sequencing, pharmacogenomics, toxicology, and other laboratory-defined tests.

Learn More

What Our Customers Are Saying

Read More

Our NGS report looks awesome. It is very complicated and complex based on a combination of being able to provide the genes expressed, clinical trials that are available for the patient to participate in, and recommended drugs the patient can use for treatment. It was a very smart design.

Mathews Plamkoodan Laboratory Director